Facial Nerve Outcomes in Vestibular Schwannoma Surgery

Anatomical Nerve Preservation High, But Hearing Loss Common in Large Tumor Surgery

A new study confirms the delicate balance surgeons must strike when removing large vestibular schwannoma (VS) tumors. Research led by Soumen Samadder, Shuvra Mandol, and Kazi Hafiz Uddin found that while surgeons can often preserve the physical structure of the facial nerve, the surgery almost always results in complete hearing loss on the affected side. Their work analyzed outcomes for 130 patients who underwent a specific posterior fossa surgical approach.

Vestibular schwannomas are benign, slow-growing tumors that develop on the nerve connecting the inner ear to the brain. As they expand in the tight space of the cerebellopontine angle (CPA), they press on critical structures like the facial nerve, which controls facial movement, and the cochlear nerve, responsible for hearing. Surgical removal aims to eliminate the tumor while protecting these nerves.

Studying the Retrosigmoid Approach in 130 Patients

The researchers examined the records of 130 patients who had surgical resection of a CPA vestibular schwannoma at their institution between January 2017 and May 2022. Every patient underwent the same procedure: the retro-sigmoid retro-mastoid sub-occipital approach. This technique accesses the tumor from the back of the skull, behind the ear.

The primary goal was maximal tumor removal with nerve preservation. To track outcomes, the team used the House-Brackmann grading system (ranging from I, normal function, to VI, total paralysis) to assess facial nerve function after surgery. They also compared pre- and post-operative hearing using pure tone audiometry. Data points included tumor size, patient symptoms, and the surgical team’s success in preserving nerve anatomy during dissection.

Large Tumors Present with Severe Symptoms, Complicating Hearing Preservation

The patient profile in this study highlights the challenge. The majority had advanced disease. A striking 75.38% had no useful hearing before surgery, and 84.61% suffered from disabling cerebellar ataxia—a loss of balance and coordination. Nearly half (46.15%) showed features of raised intracranial pressure, a serious condition caused by the tumor’s size.

Surgical results were mixed. On one hand, the rate of complete tumor excision was high at 92.30%. Surgeons also successfully maintained the anatomical continuity of the facial nerve in 87.50% of cases. This structural preservation is the first, essential step for functional recovery.

Hearing outcomes, however, were stark. Functional hearing preservation was achieved in only eight patients, or 6.2% of the cohort. This low figure reflects the reality that large tumors have usually already destroyed hearing function or that the surgical intervention required to remove them necessitates sacrificing the cochlear nerve. As the authors note in their paper, “Hearing preservation is difficult in larger tumors.”

Facial Nerve Palsy: A Persistent Impact on Quality of Life

Even with the nerve intact, postoperative facial nerve palsy is a common and life-altering complication. The House-Brackmann grades recorded in this study represent a spectrum of dysfunction, from mild weakness to complete paralysis. This can affect a person’s ability to smile, blink, close an eyelid, speak clearly, and eat without drooling.

The incidence and severity of this palsy depend on tumor size, surgical technique, and the surgeon’s skill. The study affirms that despite advances in microsurgical tools and intraoperative nerve monitoring, risk remains due to the complex, intertwined anatomy of the CPA. The facial nerve is often stretched and thinned over the surface of a large tumor, making it vulnerable during dissection.

This type of nerve injury can lead to significant changes in brain function as it adapts to the loss of normal sensory-motor feedback from the face. Research into related conditions like hyperacusis brain changes and maladaptive amygdala plasticity shows how the central nervous system reorganizes after auditory and neurological damage, which can contribute to secondary symptoms.

Implications for Patient Management and Surgical Goals

The findings have clear practical implications. For patients with large, symptomatic vestibular schwannomas, the retrosigmoid approach is a valid and effective primary management option. The high rate of total removal and anatomical nerve preservation supports its use. However, patients must be counseled that the overwhelming likelihood is permanent, single-sided deafness.

Postoperative rehabilitation becomes critical. Management focuses on protecting the eye (if blinking is impaired), potential use of facial nerve stimulation or physical therapy, and addressing the psychological impact of facial paralysis. For the hearing loss, patients may be candidates for contralateral routing of signal (CROS) hearing aids or bone-anchored hearing systems to improve sound awareness.

The study also points to the importance of monitoring and diagnostic advances. Earlier detection of smaller tumors, perhaps through more accessible MRI or with the aid of machine learning tools, could shift the surgical landscape toward scenarios where hearing preservation is more feasible. For now, in large VS cases, the surgical priority remains clear: remove the tumor to relieve life-threatening pressure while saving the facial nerve to protect a patient’s quality of life.